Mayo Clinic study finds lung cancer drug shows promise for ovarian cancer treatment - KTTC | Rochester, MN
Mayo Clinic study finds lung cancer drug shows promise for ovarian cancer treatment KTTC | Rochester, MN
Mayo Clinic study finds lung cancer drug shows promise for ovarian cancer treatment KTTC | Rochester, MN
New long-term data on ovarian cancer drug combo at SGO 2026 Stock Titan
Hidden drug reservoirs in cancer cells could explain treatment resistance Medical Xpress
Ovarian Cancer Survivor Turns Pain Into Purpose National Today
Keytruda Combo Extends Survival in Ovarian Cancer Trial: Expert Insights Cure Today
Risk of Breast Cancer After Ovarian Cancer in Women With BRCA1/2 Variants The ASCO Post
Caris Life Sciences Introduces Powerful New Caris AI Insights to Identify Early Platinum Resistance in Ovarian Cancer PR Newswire
Susquehanna Valley woman brings strength, resilience to fight against ovarian cancer WGAL
Ovarian Cancer Diagnostics Industry Set for Strong Growth at 7% CAGR Through 2036 openPR.com
Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer The Manila Times
Mayo Clinic study finds lung cancer drug shows promise for ovarian cancer treatment KTTC | Rochester, MN
Rewiring Immune System Offers New Path to Better Ovarian Cancer Treatment UC San Diego Today
Lynparza nears broader reimbursement for ovarian cancer maintenance therapy koreabiomed.com
'How I knew I had ovarian cancer’: Survivors and caregiver discuss symptoms UT MD Anderson
Judge throws out $950 million punitive damages award against J&J in talc trial Reuters
FDA Approves Myriad Genetics' MyChoice CDx Test for Advanced Ova GuruFocus
Lung cancer drug offers a surprising new treatment against ovarian cancer Mayo Clinic News Network
FDA approves genetic test to match ovarian cancer patients to Zejula Stock Titan
Historic Breakthrough in Platinum-Resistant Ovarian Cancer Treatment(2) Cure Today
Expert Explains Keytruda Combo Survival Gains in Resistant Ovarian Cancer Cure Today
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026 The Manila Times
More Than a Notch: New Discovery May Improve Ovarian Cancer Treatment UNM HSC Newsroom
Cannabis derivatives could provide new ovarian cancer treatments Frontiers
What Was 2025’s Biggest News in Ovarian Cancer? Oncology News Central
Ovarian cancer Nature
Can AI help predict outcomes in ovarian cancer? michiganmedicine.org
One Surgery Could Prevent Most Ovarian Cancers The American College of Surgeons
UCLA scientists develop off-the-shelf immunotherapy for ovarian cancer Newsroom | UCLA
Run the Sandy Sprint 5K at the Navy Yard this April PhillyVoice
Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial Nature
American Cancer Society and Break Through Cancer Unite to Outsmart Ovarian Cancer American Cancer Society Press Room
“We Need More Advocacy”: Tackling the Biggest Challenges in Ovarian Cancer Care Oncology News Central
Immunocompetent C57BL/6 syngeneic mouse ovarian cancer models with defined genetic alterations Nature
Genomic alterations linked to recurrence risk in high-grade serous ovarian cancer revealed by deep targeted sequencing Nature
VIDEO: Better ovarian cancer screening, prevention needed Healio
R-DXd Elicits Encouraging Efficacy in Ovarian Cancer Targeted Oncology
The Latest Updates in Ovarian Cancer Treatment Oncology News Central
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA Nature
New nanoparticles stimulate the immune system to attack ovarian tumors MIT News
Ovarian Cancer May Finally Get a More Effective Treatment the-scientist.com